0 CHECKOUT

Organophosphate And Carbamate Poisoning - Pipeline Review, H2 2015

  • ID: 3455152
  • September 2015
  • 34 pages
  • Global Markets Direct
1 of 4

Organophosphate And Carbamate Poisoning - Pipeline Review, H2 2015

Summary

The report ‘Organophosphate And Carbamate Poisoning - Pipeline Review, H2 2015’, provides an overview of the Organophosphate And Carbamate Poisoning’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Organophosphate And Carbamate Poisoning, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Organophosphate And Carbamate Poisoning and special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug READ MORE >

Note: Product cover images may vary from those shown
2 of 4

List of Tables

List of Figures

Introduction

REPORT COVERAGE

Organophosphate And Carbamate Poisoning Overview

Therapeutics Development

Pipeline Products for Organophosphate And Carbamate Poisoning - Overview

Pipeline Products for Organophosphate And Carbamate Poisoning - Comparative Analysis

Organophosphate And Carbamate Poisoning - Therapeutics under Development by Companies

Organophosphate And Carbamate Poisoning - Therapeutics under Investigation by Universities/Institutes

Organophosphate And Carbamate Poisoning - Pipeline Products Glance

Early Stage Products

Organophosphate And Carbamate Poisoning - Products under Development by Companies

Organophosphate And Carbamate Poisoning - Products under Investigation by Universities/Institutes

Organophosphate And Carbamate Poisoning - Companies Involved in Therapeutics Development

Countervail Corporation

Organophosphate And Carbamate Poisoning - Therapeutics Assessment

Assessment by Monotherapy Products

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Drug Profiles

AM-132 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

galantamine - Drug Profile

Product Description

Mechanism of Action

R&D Progress

PlantVax-1502-H-N - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Small Molecule for Organophosphate Poisoning - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit PARP-1 and Activate AChE for Organophosphates Poisoning - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Activate Acetylcholinesterase for Organophosphate Poisoning - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Organophosphate And Carbamate Poisoning - Discontinued Products

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Number of Products under Development for Organophosphate And Carbamate Poisoning, H2 2015

Number of Products under Development for Organophosphate And Carbamate Poisoning - Comparative Analysis, H2 2015

Number of Products under Development by Companies, H2 2015

Number of Products under Investigation by Universities/Institutes, H2 2015

Comparative Analysis by Early Stage Products, H2 2015

Products under Development by Companies, H2 2015

Products under Investigation by Universities/Institutes, H2 2015

Organophosphate And Carbamate Poisoning - Pipeline by Countervail Corporation, H2 2015

Assessment by Monotherapy Products, H2 2015

Number of Products by Stage and Target, H2 2015

Number of Products by Stage and Mechanism of Action, H2 2015

Number of Products by Stage and Route of Administration, H2 2015

Number of Products by Stage and Molecule Type, H2 2015

Organophosphate And Carbamate Poisoning - Discontinued Products, H2 2015

List of Figures

Number of Products under Development for Organophosphate And Carbamate Poisoning, H2 2015

Number of Products under Development for Organophosphate And Carbamate Poisoning - Comparative Analysis, H2 2015

Number of Products under Development by Companies, H2 2015

Number of Products under Investigation by Universities/Institutes, H2 2015

Comparative Analysis by Early Stage Products, H2 2015

Assessment by Monotherapy Products, H2 2015

Number of Products by Top 10 Targets, H2 2015

Number of Products by Stage and Top 10 Targets, H2 2015

Number of Products by Top 10 Mechanism of Actions, H2 2015

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015

Number of Products by Top 10 Routes of Administration, H2 2015

Number of Products by Stage and Top 10 Routes of Administration, H2 2015

Number of Products by Top 10 Molecule Types, H2 2015

Number of Products by Stage and Top 10 Molecule Types, H2 2015

Note: Product cover images may vary from those shown
3 of 4

Countervail Corporation

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Amneal Pharmaceuticals LLC.
  • Amgen Inc.
  • LEO Laboratories Ltd.
  • Pfizer Inc.
  • Roche Diagnostics Ltd.
  • Merck & Co., Inc.
  • Sanofi S.A.